Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions Matthew P. RutmanJohn R. HornRichard G. Stefanacci Review Article Open access 12 March 2021 Pages: 293 - 302
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects Carla RognoniArianna BertolaniClaudio Jommi Systematic Review Open access 09 March 2021 Pages: 303 - 319
Overall Efficacy and Safety of Safinamide in Parkinson’s Disease: A Systematic Review and a Meta-analysis Riccardo GiossiFederica CarraraFrancesco Scaglione Systematic Review Open access 05 March 2021 Pages: 321 - 339
Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis Hsin-Yu ChenShih-Hsiang OuYi-Chia Su Systematic Review 11 March 2021 Pages: 341 - 351
Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review Margaret M. BuckAlexa M. HaddonCourtney A. Montepara Systematic Review 07 March 2021 Pages: 353 - 369
Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece George GourzoulidisCharalampos TzanetakosGeorgia Kourlaba Original Research Article 09 March 2021 Pages: 371 - 380
Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan Yugo ChisakiYoshiki KuwadaYoshitaka Yano Original Research Article 05 March 2021 Pages: 381 - 389
Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration Narihisa MiyachiOleh ZagrijtschukAlbert Qin Original Research Article 16 March 2021 Pages: 391 - 404
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use Sheridan M. Hoy Adis Drug Q&A Open access 16 March 2021 Pages: 405 - 412
Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease Alberto CastagnaCiro ManzoGiovanni Ruotolo Correction 27 February 2021 Pages: 413 - 413
